Bilateral renal angiomyolipomas and subependymal giant cell astrocytoma associated with tuberous sclerosis complex: A case report and review of the literature
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
O’Callaghan FJ, Shiell AW, Osborne JP, Martyn CN. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998; 351(9114): 1490.O’CallaghanFJShiellAWOsborneJPMartynCNPrevalence of tuberous sclerosis estimated by capture-recapture analysisLancet19983519114149010.1016/S0140-6736(05)78872-3Search in Google Scholar
Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006; 355(13): 1345-1356.CrinoPBNathansonKLHenskeEPThe tuberous sclerosis complexN Engl J Med2006355131345135610.1201/9780849358364.ch22Search in Google Scholar
Jansen FE, van Nieuwenhuizen O, van Huffelen AC. Tuberous sclerosis complex and its founders. J Neurol Neurosurg Psychiatry. 2004; 75(5): 770.JansenFEvan NieuwenhuizenOvan HuffelenACTuberous sclerosis complex and its foundersJ Neurol Neurosurg Psychiatry200475577010.1136/jnnp.2003.027524176355815090576Search in Google Scholar
Brigo F, Lattanzi S, Trinka E, Nardone R, Bragazzi NL, Ruggieri M, et al. First descriptions of tuberous sclerosis by Désiré-Magloire Bourneville (18401909. Neuro-pathology. 2018; 38(6):577-582.BrigoFLattanziSTrinkaENardoneRBragazziNLRuggieriMet alFirst descriptions of tuberous sclerosis by Désiré-Magloire Bourneville (18401909Neuro-pathology2018386577582Search in Google Scholar
Rodrigues DA, Gomes CM, Costa IM. Tuberous sclerosis complex. Ann Bras Dermatol. 2012; 87(2): 184-196.RodriguesDAGomesCMCostaIMTuberous sclerosis complexAnn Bras Dermatol201287218419610.1590/S0365-05962012000200001Search in Google Scholar
Portocarrero LKL, Quental KN, Samorano LP, de Oliveira ZNP, Rivitti-Machado MCDM. Tuberous sclerosis complex: review based on new diagnostic criteria. Ann Bras Dermatol. 2018; 93(3): 323-331.PortocarreroLKLQuentalKNSamoranoLPdeOliveira ZNPRivitti-MachadoMCDMTuberous sclerosis complex: review based on new diagnostic criteriaAnn Bras Dermatol201893332333110.1590/abd1806-4841.20186972600107729924239Search in Google Scholar
Pirson Y. Tuberous sclerosis complex-associated kidney angiomyolipoma: From contemplation to action. Nephrol Dial Transplant. 2013; 28(7): 1680-1685.PirsonYTuberous sclerosis complex-associated kidney angiomyolipoma: From contemplation to actionNephrol Dial Transplant20132871680168510.1093/ndt/gft00923413089Search in Google Scholar
Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4): 243-254.NorthrupHKruegerDA; International Tuberous Sclerosis Complex Consensus GroupTuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferencePediatr Neurol201349424325410.1016/j.pediatrneurol.2013.08.001408068424053982Search in Google Scholar
Gabardi S, Baroletti SA Everolimus: A proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology. Pharma-cotherapy. 2010; 30(10): 1044-1056.GabardiSBarolettiSA Everolimus: A proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiologyPharma-cotherapy201030101044105610.1592/phco.30.10.104420874042Search in Google Scholar
Capal JK, Franz DN. Profile of everolimus in the treatment of tuberous sclerosis complex: An evidence-based review of its place in therapy. Neuropsychiatr Dis Treat. 2016; 12: 2165-2172.CapalJKFranzDNProfile of everolimus in the treatment of tuberous sclerosis complex: An evidence-based review of its place in therapyNeuropsychiatr Dis Treat2016122165217210.2147/NDT.S91248500359527601910Search in Google Scholar
Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015; 14(7): 733-745.CuratoloPMoaveroRdeVries PJNeurological and neuropsychiatric aspects of tuberous sclerosis complexLancet Neurol201514773374510.1016/S1474-4422(15)00069-1Search in Google Scholar
Budde K, Gaedeke J. Tuberous sclerosis complex-associated angiomyolipomas: Focus on mTOR inhibition. Am J Kidney Dis. 2012; 59(2): 276-283.BuddeKGaedekeJTuberous sclerosis complex-associated angiomyolipomas: Focus on mTOR inhibitionAm J Kidney Dis201259227628310.1053/j.ajkd.2011.10.013Search in Google Scholar
McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011; 364(17): 1595-1606.McCormackFXInoueYMossJSingerLGStrangeCNakataKet alEfficacy and safety of sirolimus in lymphangioleiomyomatosisN Engl J Med2011364171595160610.1056/NEJMoa1100391Search in Google Scholar
Jacks SK, Witman PM. Tuberous sclerosis complex: An update for dermatologists. Pediatr Dermatol. 2015; 32(5): 563-570.JacksSKWitmanPMTuberous sclerosis complex: An update for dermatologistsPediatr Dermatol201532556357010.1111/pde.12567Search in Google Scholar
Murray TE, Doyle F, Lee M. Transarterial embolization of angiomyolipoma: A systematic review. J Urol. 2015; 194(3): 635-639.MurrayTEDoyleFLeeMTransarterial embolization of angiomyolipoma: A systematic reviewJ Urol2015194363563910.1016/j.juro.2015.04.081Search in Google Scholar
Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2013; 381(9861): 125-132.FranzDNBelousovaESparaganaSBebinEMFrostMKupermanRet alEfficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trialLancet2013381986112513210.1016/S0140-6736(12)61134-9Search in Google Scholar
Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised, double-blind, placebocontrolled trial. Lancet. 2013; 381(9869): 817-824.BisslerJJKingswoodJCRadzikowskaEZonnenbergBAFrostMBelousovaEet alEverolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised, double-blind, placebocontrolled trialLancet2013381986981782410.1016/S0140-6736(12)61767-XSearch in Google Scholar
Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Belousova E, Frost MD, et al. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. PLoS One. 2017; 12(8): e0180939.BisslerJJKingswoodJCRadzikowskaEZonnenbergBABelousovaEFrostMDet alEverolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 studyPLoS One2017128e018093910.1371/journal.pone.0180939554989328792952Search in Google Scholar
Toriu N, Mizuno H, Sawa N, Sumida K, Suwabe T, Hayami N, et al. Everolimus reduces the size of tuberous sclerosis complex-related huge renal angiomyolipomas exceeding 20 cm in the longest diameter. Case Rep Oncol. 2018; 11(2): 258-267.ToriuNMizunoHSawaNSumidaKSuwabeTHayamiNet alEverolimus reduces the size of tuberous sclerosis complex-related huge renal angiomyolipomas exceeding 20 cm in the longest diameterCase Rep Oncol201811225826710.1159/000488704598159929867433Search in Google Scholar
Kotulska K, Borkowska J, Roszkowski M, Mandera M, Daszkiewicz P, Drabik K, et al., Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol. 2014; 50(4): 307–312.KotulskaKBorkowskaJRoszkowskiMManderaMDaszkiewiczPDrabikKet alSurgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patientsPediatr Neurol201450430731210.1016/j.pediatrneurol.2013.12.00424507694Search in Google Scholar
Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, et al.. Subependymal giant cell astrocytoma: Diagnosis, screening, and treatment. Recommendations from the International Tuberous sclerosis Complex Consensus Conference 2012. Pediatr Neurol. 2013; 49(6): 439-444.RothJRoachESBartelsUJóźwiakSKoenigMKWeinerHLet alSubependymal giant cell astrocytoma: Diagnosis, screening, and treatmentRecommendations from the International Tuberous sclerosis Complex Consensus Conference 2012. Pediatr Neurol201349643944410.1016/j.pediatrneurol.2013.08.01724138953Search in Google Scholar
Stein JR, Reidman DA. Imaging manifestations of a subependymal giant cell astrocytoma in tuberous sclerosis. Case Rep Radiol. 2016; 2016: 3750450.SteinJRReidmanDAImaging manifestations of a subependymal giant cell astrocytoma in tuberous sclerosisCase Rep Radiol20162016375045010.1155/2016/3750450475297426942030Search in Google Scholar
